ClinicalTrials.Veeva

Menu

Zynamite® in Cognition and Mood in University Students

U

University of Jaén

Status

Completed

Conditions

University Student

Treatments

Other: Zynamite

Study type

Interventional

Funder types

Other

Identifiers

NCT06651710
University

Details and patient eligibility

About

This study examines the effects of a single dose of ZynS on cognitive function (memory, concentration, attention, and mental agility) in college students and will test the efficacy of this treatment on mood (anger, fatigue, vigor, agreeableness, tension, and depression).

Enrollment

119 patients

Sex

All

Ages

18 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be an active undergraduate or graduate student
  • Be between 18 and 25 years of age
  • Be healthy and free of any relevant medical condition or disease.

Exclusion criteria

  • Suffer from chronic diseases such as asthma, type 1 diabetes, thyroid diseases (such as hypothyroidism or hyperthyroidism), autoimmune disorders (such as Crohn's disease) and psychiatric conditions such as anxiety disorders, major depression, eating disorders (anorexia, bulimia), attention deficit hyperactivity disorder (ADHD), among others; ii) Pregnancy or breastfeeding.
  • Known intolerance, hypersensitivity or allergies to any of the ingredients of the products under investigation;
  • Intestinal absorption problems, as well as learning difficulties, dyslexia, eye problems or color blindness;
  • Intake of psychoactive substances or medications that may influence the results of the study, such as consuming >500 mg of caffeine per day (>6 cups of 150 ml filtered coffee) and/or alcohol;
  • Having comprehension or communication difficulties that prevent full understanding of the informed consent or effective participation in the study, such as autism spectrum disorders, aphasia, or intellectual disability.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

119 participants in 3 patient groups

Placebo
No Intervention group
Zynamite® soluble 100mg
Experimental group
Treatment:
Other: Zynamite
Zynamite® soluble 150mg
Experimental group
Treatment:
Other: Zynamite

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems